| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/27/2011 | US20110020468 Silver Oxide Formulations Having Improved Whiteness Characteristics |
| 01/27/2011 | US20110020442 Taste Masked Oral Composition of Telithromycin |
| 01/27/2011 | US20110020424 Use of the irritating principal oleocanthal in olive oil, as well as structurally and functionally similar compounds |
| 01/27/2011 | US20110020408 multilayered modified release formulation comprising amoxicillin and clavulanate |
| 01/27/2011 | US20110020406 Viral inactivation process |
| 01/27/2011 | US20110020404 Diagnostic method and kit |
| 01/27/2011 | US20110020403 immunizing composition |
| 01/27/2011 | US20110020402 Method For Identification, Isolation And Production Of Antigens To A Specific Pathogen |
| 01/27/2011 | US20110020400 Probiotic bifidobacterium strains |
| 01/27/2011 | US20110020399 Vaccines and Immunomodulatory Therapies for Tularemia |
| 01/27/2011 | US20110020398 Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus |
| 01/27/2011 | US20110020397 Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as hbv and hdv entry inhibitors |
| 01/27/2011 | US20110020396 HIV Envelope-CD4 Complexes and Hybrids |
| 01/27/2011 | US20110020393 Method of Producing Japanese Encephalitis Vaccine Stably Storable Over Long Time and Use of the Vaccine |
| 01/27/2011 | US20110020391 Recombinant modified vaccinia virus ankara (mva)-based vaccine for the avian flu |
| 01/27/2011 | US20110020386 Vaccines and compositions against streptococcus pneumoniae |
| 01/27/2011 | US20110020385 COMBINATIONS OF PNEUMOCOCCAL RrgB CLADES |
| 01/27/2011 | US20110020384 Therapeutic tb vaccine |
| 01/27/2011 | US20110020383 Novel genes and proteins of brachyspira hyodysenteriae and uses thereof |
| 01/27/2011 | US20110020382 Nucleic acid and amino acid sequences relating to staphylococcus epidermidis for diagnostics and therapeutics |
| 01/27/2011 | US20110020381 Influenza vaccine formulation |
| 01/27/2011 | US20110020375 Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use |
| 01/27/2011 | US20110020373 Ige directed dna vaccination |
| 01/27/2011 | US20110020357 Anti human immunodeficiency antibodies and uses thereof |
| 01/27/2011 | US20110020356 Therapeutic clostridium difficile antibody compositions |
| 01/27/2011 | US20110020355 Treatment and prevention of gardnerella vaginalis infections |
| 01/27/2011 | US20110020352 Endogenous retroviruses up-regulated in prostate cancer |
| 01/27/2011 | US20110020343 Auristatin drug linker conjugates |
| 01/27/2011 | US20110020338 5Imidazoquinolines and Pyrimidine Derivatives as Potent Modulators of VEGF-Driven Angiogenic Processes |
| 01/27/2011 | US20110020328 Antibody formulations |
| 01/27/2011 | US20110020325 Methods for reducing granulomatous inflammation |
| 01/27/2011 | US20110020323 Gram-positive bacteria specific binding compounds |
| 01/27/2011 | US20110020321 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/27/2011 | US20110020315 Treatment of inflammatory illnesses with ace2 |
| 01/27/2011 | US20110020308 Expression of transgenic t cell receptors in lak-t cells |
| 01/27/2011 | US20110020306 Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof |
| 01/27/2011 | US20110020305 Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof |
| 01/27/2011 | US20110020304 Synbiotic mixture |
| 01/27/2011 | US20110020296 Methods for treating diseases and increasing longevity |
| 01/27/2011 | US20110020290 Bacteriophage-containing therapeutic agents |
| 01/27/2011 | US20110020284 Probiotic bifidobacterium strains |
| 01/27/2011 | US20110020279 Rabies cure |
| 01/27/2011 | US20110020278 Inhibitors of flaviviridae viruses |
| 01/27/2011 | US20110020277 Dioxolane and Dioxolanone Fused Indolobenzadiazepine HCV NS5B Inhibitors |
| 01/27/2011 | US20110020276 Pyrrolidine Fused Indolobenzadiazepine HCV NS5B Inhibitors |
| 01/27/2011 | US20110020275 Compounds for the Treatment of Hepatitis C |
| 01/27/2011 | US20110020272 Combination therapy for treating hepatitis viral infection |
| 01/27/2011 | US20110020266 G-CSF Conjugates |
| 01/27/2011 | US20110020265 Use of oligomers of lactic acid in the treatment of gynaecological disorders |
| 01/27/2011 | US20110020250 Personal-care composition comprising a hydrocarbon wax and a polar oil |
| 01/27/2011 | US20110020234 Rna interference mediating small rna molecules |
| 01/27/2011 | US20110020227 Polysaccharide-containing block copolmer particles and uses thereof |
| 01/27/2011 | US20110020225 Porous polymer particles immobilized with charged molecules and method for preparing the same |
| 01/27/2011 | US20110020216 Scaffolds for cell collection or elimination |
| 01/27/2011 | DE102010027315A1 Verfahren zur Entwicklung einer als Schaum auf die Haut zu applizierende flüssige Zusammensetzung sowie eine topisch applizierbare Zusammensetzung A process for the development of a foam on the skin as a liquid composition to be applied, and a topically applicable composition |
| 01/27/2011 | DE102009034130A1 Aqueous pharmaceutical preparation, useful for the prevention of renal failure, comprises an aminoglycoside antibiotic, gelatin and/or its derivatives and/or a gelatin-like protein or polypeptide and sodium chloride |
| 01/27/2011 | DE102009028015A1 Use of composition comprising proteasome inhibitor, nucleoside analog and interferon for producing an agent for treating hepatitis-C infection, and for treating against interferon and nucleoside analog resistant hepatitis-C virus infection |
| 01/27/2011 | CA2806198A1 Silver oxide formulations having improved whiteness characteristics |
| 01/27/2011 | CA2768851A1 Inhibitors of mtor kinase as anti-viral agents |
| 01/27/2011 | CA2768301A1 Universal microbial diagnosis, detection, quantification, and specimen-targeted therapy |
| 01/27/2011 | CA2767088A1 Inhibitors of flaviviridae viruses |
| 01/26/2011 | EP2278024A1 Epitope cluster from NY-ESO-1 for the induction of anti-tumor immunogenicity |
| 01/26/2011 | EP2278023A1 Epitope cluster from Melan-A/MART-1 for the induction of anti-tumor immunogenicity |
| 01/26/2011 | EP2278013A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2278012A2 Avirulent, immunogenic flavivirus chimeras |
| 01/26/2011 | EP2278011A2 Neisseria meningitidis antigens |
| 01/26/2011 | EP2278010A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278009A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278008A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278007A1 Conserved neisserial antigens |
| 01/26/2011 | EP2278006A2 Neisserial antigens |
| 01/26/2011 | EP2278004A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 01/26/2011 | EP2277911A1 Treatment of viral infections Apo E |
| 01/26/2011 | EP2277899A2 Antimicrobial peptides |
| 01/26/2011 | EP2277898A2 Rapamycin analogues |
| 01/26/2011 | EP2277897A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2277891A1 CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS POLYMERASE PAc-PB1n COMPLEX AND USES THEREOF |
| 01/26/2011 | EP2277878A1 Process for production of ethynylthymidine compound using 5-methyluridine as starting raw material |
| 01/26/2011 | EP2277862A2 5-hydroxy-4-aminomethyl-1-cyclohexane or (cycloheptyl)--3-alkoxycarbonyl indole derivatives, pharmaceutically acceptable antiviral salts thereof and a method for the production thereof |
| 01/26/2011 | EP2277549A2 Therapeutic polyanhydride compounds for drug delivery |
| 01/26/2011 | EP2277541A1 Multivalent vaccine composition |
| 01/26/2011 | EP2277540A2 Polyanionic polymer adjuvants for haemophilus influenza B saccharide vaccines |
| 01/26/2011 | EP2277539A2 Neisseria meningitidis conjugate combination vaccine |
| 01/26/2011 | EP2277537A2 Neisseria meningitidis conjugate combination vaccine |
| 01/26/2011 | EP2277536A2 Purification of bacterial capsular polysaccharides |
| 01/26/2011 | EP2277535A2 Vaccine |
| 01/26/2011 | EP2277526A1 Pharmaceutical composition with tetrahydroisohumulone |
| 01/26/2011 | EP2277506A1 Non-polar buccal spray of a sedative |
| 01/26/2011 | EP2276771A1 Solid forms of an anti-hiv phosphoindole compound |
| 01/26/2011 | EP2276769A1 New peptidomimetic compounds |
| 01/26/2011 | EP2276766A1 Tricyclic antibiotics |
| 01/26/2011 | EP2276765A1 Salinosporamide derivatives as proteasome inhibitors |
| 01/26/2011 | EP2276764A1 Compounds for the treatment of hepatitis c |
| 01/26/2011 | EP2276725A1 New ruthenium complexes as catalysts for metathesis reactions |
| 01/26/2011 | EP2276488A1 5imidazoquinolines and pyrimidine derivatives as potent modulators of vegf-driven angiogenic processes |
| 01/26/2011 | EP2276486A2 Novel substituted imidazoquinolines |
| 01/26/2011 | EP2276484A1 An antimicrobial composition |
| 01/26/2011 | EP2276479A2 Prodrugs of neuraminidase inhibitors |
| 01/26/2011 | EP2276478A1 Methods of administering prostratin and structural analogs thereof |
| 01/26/2011 | EP2276464A2 Combinations of antiviral agents and other compounds |